Multidimensional regulation of the cytochrome P450 metabolic network in pulmonary arterial hypertension: Homeostatic imbalance, pathological drivers, and environmental interactions.
文献摘要
The cytochrome P450 superfamily represents a key metabolic regulatory node in the pathophysiology of pulmonary arterial hypertension (PAH). Dysregulation of its homeostatic network directly drives disease progression. This review systematically delineates 3 core axes via which the CYP metabolic network modulates PAH pathogenesis. These axes include functional impairment of the protective CYP2C/J-epoxyeicosatrienoic acid axis, aberrant activation of the deleterious CYP4A/F-20-hydroxyeicosatetraenoic acid axis, and sustained overactivation of the environmental responsive aryl hydrocarbon receptor/CYP1 axis. This article provides an in-depth analysis of the molecular mechanisms, crosstalk, and synergistic pathogenic effects of these 3 axes, which collectively drive pulmonary vasoconstriction, vascular remodeling, and inflammatory cascades in PAH. These 3 factors form a positive feedback vicious cycle through oxidative stress and substrate competition, synergistically promoting pulmonary vasoconstriction, vascular remodeling, and inflammatory cascades, while smoking, obesity, sex hormones, and immune cells mediate differences in pathogenic patterns across populations. Additionally, this review summarizes 3 classes of targeted agents-soluble epoxide hydrolase inhibitors, CYP4 inhibitors, and CYP1A1 inhibitors-and comprehensively evaluates their translational potential, clinical limitations, and optimization strategies such as lung-targeted delivery. Furthermore, the clinical value of metabolic biomarkers, including the epoxyeicosatrienoic acids/dihydroxyeicosatrienoic acids ratio and plasma 20-hydroxyeicosatetraenoic acid, for PAH subtyping and prognostic assessment is discussed. This review aimed to provide an integrated theoretical framework for elucidating the metabolic etiology of PAH and advancing the development of precision therapies. SIGNIFICANCE STATEMENT: Imbalanced cytochrome P450 metabolic networks play a critical role in pulmonary arterial hypertension progression, however, systematic integration of crosstalk among multiple relevant pathways remains lacking. This review delineates 3 interconnected cytochrome P450-dependent pathogenic axes, explaining patient-specific disease patterns and supporting advances in metabolic biomarkers and precision therapeutic strategies for pulmonary arterial hypertension.